The picato gel (ingenol mebutate) market comprises the development, formulation, and commercialization of the picato gel containing ingenol mebutate as an active pharmaceutical ingredient used for the treatment of actinic keratosis topically. Ingenol mebutate is obtained from the Euphoria peplus, is a traditional medicine used in the management of skin conditions like warts and cancer. Ingenol mebutate is a well-tolerated treatment for actinic keratosis, with good patient adherence due to its short treatment period.